Exponent, Inc. (NASDAQ:EXPO - Get Free Report) CEO Catherine Corrigan sold 4,896 shares of the business's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $71.09, for a total value of $348,056.64. Following the completion of the sale, the chief executive officer owned 81,342 shares in the company, valued at $5,782,602.78. The trade was a 5.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Exponent Price Performance
Shares of EXPO traded up $0.43 during mid-day trading on Wednesday, hitting $70.03. 697,309 shares of the company's stock were exchanged, compared to its average volume of 385,640. Exponent, Inc. has a 52 week low of $63.81 and a 52 week high of $115.75. The company has a market cap of $3.54 billion, a PE ratio of 35.02 and a beta of 0.89. The company has a 50-day simple moving average of $73.01 and a 200 day simple moving average of $78.36.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The business had revenue of $132.87 million for the quarter, compared to analyst estimates of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The firm's revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.57 earnings per share. On average, analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Friday, September 5th will be issued a $0.30 dividend. The ex-dividend date is Friday, September 5th. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. Exponent's dividend payout ratio (DPR) is presently 60.00%.
Institutional Trading of Exponent
Several institutional investors and hedge funds have recently bought and sold shares of EXPO. Bank of Montreal Can boosted its position in shares of Exponent by 1.5% during the 4th quarter. Bank of Montreal Can now owns 8,747 shares of the business services provider's stock valued at $779,000 after purchasing an additional 131 shares in the last quarter. Bessemer Group Inc. increased its holdings in Exponent by 21.7% in the second quarter. Bessemer Group Inc. now owns 829 shares of the business services provider's stock worth $62,000 after purchasing an additional 148 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in Exponent by 2.7% in the first quarter. State of Alaska Department of Revenue now owns 5,946 shares of the business services provider's stock valued at $481,000 after buying an additional 155 shares during the period. Mitchell & Pahl Private Wealth LLC lifted its stake in Exponent by 2.5% in the first quarter. Mitchell & Pahl Private Wealth LLC now owns 6,709 shares of the business services provider's stock valued at $544,000 after buying an additional 164 shares during the period. Finally, Portside Wealth Group LLC boosted its holdings in shares of Exponent by 6.0% during the 1st quarter. Portside Wealth Group LLC now owns 2,993 shares of the business services provider's stock worth $243,000 after buying an additional 170 shares in the last quarter. Institutional investors own 92.37% of the company's stock.
About Exponent
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.